Large commercial scale lentiviral vector production system and vectors produced thereby
AssigneeThe Children's Hospital of Philadelphia
InventorsKatherine A. High, J. Fraser Wright, Bernd Hauck, Guang Qu
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Children's Hospital of Philadelphia
InventorsKatherine A. High, J. Fraser Wright, Bernd Hauck, Guang Qu
Estimating the term…
In accordance with the present invention, a method for increasing the yield of rLV vector particles comprising a trans gene encoding a therapeutic protein or fragment thereof is disclosed. In one approach, cells are transfected with plasmids encoding the necessary components for rLV production using a calcium chloride transfection mix at pH 7.1 wherein the calcium chloride and plasmids form a complex which is added to the cells at a constant speed. The cells are then incubated for a suitable time period wherein virus particle media is collected at least twice during the incubation period and stored in a cold storage unit, thereby reducing virus inactivation.
A method for increasing the production of recombinant lentivirus (rLV) comprising a therapeutically beneficial transgene, comprising
Dependencies are inferred from the claim text.